| Dr Carol Silviu Struminger, DO | |
|
1625 Oregon Pike, Lancaster, PA 17601-4335 | |
| (717) 925-2995 | |
| Not Available |
| Full Name | Dr Carol Silviu Struminger |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 1625 Oregon Pike, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073530424 | NPI | - | NPPES |
| OS009696L | Other | PA | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS009696L (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Patient First Pennsylvania Medical Group Pllc | 5193900280 | 148 |
News Archive
Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders, announced today the submission to the Comisión Federal para la Protección contra Riesgos Sanitarios in Mexico for Kanuma as a treatment for patients with lysosomal acid lipase deficiency (LAL Deficiency), a rare genetic disease with significant morbidity and early mortality.
Medical software company FiatLux Imaging, Inc., located in Redmond, WA, announces the availability of FiatLux Visualize(TM) Free, advanced 2D/3D visualization software for CT and MRI imaging data. The free software is available for any healthcare professional via download from www.FiatLuxImaging.com. There is no charge for download or use.
A counterintuitive experiment has resulted in one of the longest recorded life-span extensions in any organism and opened a new door for anti-aging research in humans.
Pfizer and Kohlberg Kravis Roberts & Co L.P. (together with its affiliates, "KKR") today announced they have entered into an agreement whereby an affiliate of KKR will acquire Pfizer's Capsugel business for $2.375 billion in cash. Capsugel, the world leader in hard capsules and an innovator in drug-delivery systems, generated approximately $750 million in revenue and manufactured more than 180 billion hard capsules in 2010.
The administration of infliximab after intestinal resective surgery was found to be effective at preventing endoscopic and histological recurrence of Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
› Verified 1 days ago
| Entity Name | Patient First Pennsylvania Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194039560 PECOS PAC ID: 5193900280 Enrollment ID: O20110505000465 |
News Archive
Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders, announced today the submission to the Comisión Federal para la Protección contra Riesgos Sanitarios in Mexico for Kanuma as a treatment for patients with lysosomal acid lipase deficiency (LAL Deficiency), a rare genetic disease with significant morbidity and early mortality.
Medical software company FiatLux Imaging, Inc., located in Redmond, WA, announces the availability of FiatLux Visualize(TM) Free, advanced 2D/3D visualization software for CT and MRI imaging data. The free software is available for any healthcare professional via download from www.FiatLuxImaging.com. There is no charge for download or use.
A counterintuitive experiment has resulted in one of the longest recorded life-span extensions in any organism and opened a new door for anti-aging research in humans.
Pfizer and Kohlberg Kravis Roberts & Co L.P. (together with its affiliates, "KKR") today announced they have entered into an agreement whereby an affiliate of KKR will acquire Pfizer's Capsugel business for $2.375 billion in cash. Capsugel, the world leader in hard capsules and an innovator in drug-delivery systems, generated approximately $750 million in revenue and manufactured more than 180 billion hard capsules in 2010.
The administration of infliximab after intestinal resective surgery was found to be effective at preventing endoscopic and histological recurrence of Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carol Silviu Struminger, DO 5000 Cox Rd, Glen Allen, VA 23060-9263 Ph: () - | Dr Carol Silviu Struminger, DO 1625 Oregon Pike, Lancaster, PA 17601-4335 Ph: (717) 925-2995 |
News Archive
Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders, announced today the submission to the Comisión Federal para la Protección contra Riesgos Sanitarios in Mexico for Kanuma as a treatment for patients with lysosomal acid lipase deficiency (LAL Deficiency), a rare genetic disease with significant morbidity and early mortality.
Medical software company FiatLux Imaging, Inc., located in Redmond, WA, announces the availability of FiatLux Visualize(TM) Free, advanced 2D/3D visualization software for CT and MRI imaging data. The free software is available for any healthcare professional via download from www.FiatLuxImaging.com. There is no charge for download or use.
A counterintuitive experiment has resulted in one of the longest recorded life-span extensions in any organism and opened a new door for anti-aging research in humans.
Pfizer and Kohlberg Kravis Roberts & Co L.P. (together with its affiliates, "KKR") today announced they have entered into an agreement whereby an affiliate of KKR will acquire Pfizer's Capsugel business for $2.375 billion in cash. Capsugel, the world leader in hard capsules and an innovator in drug-delivery systems, generated approximately $750 million in revenue and manufactured more than 180 billion hard capsules in 2010.
The administration of infliximab after intestinal resective surgery was found to be effective at preventing endoscopic and histological recurrence of Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
› Verified 1 days ago
Jon David Lepley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 540 Duke St, Lancaster, PA 17602 Phone: 717-544-4950 | |
Dr. Lindsi Anne Dearment, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1871 Santa Barbara Dr Ste 1, Lancaster, PA 17601 Phone: 717-560-1970 Fax: 717-560-2278 | |
Emily Kirchner, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 N Duke St, Lancaster, PA 17602 Phone: 717-544-4940 | |
Dr. John T Cotter Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2207 Oregon Pike Ste 202, Lancaster, PA 17601 Phone: 717-560-6470 Fax: 717-560-6472 | |
Dr. Spencer D Phillips, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2113 Manor Ridge Dr, Lancaster, PA 17603 Phone: 717-517-7841 Fax: 717-517-7853 | |
Danielle J Miller, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3045 Marietta Ave, Lancaster, PA 17601 Phone: 717-898-2900 | |
Dr. Christine Janouschek, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 210 S Prince St, Lancaster, PA 17603 Phone: 717-393-7709 |